ArticleJTCVS techniques2025
Early outcomes of robotic management of aberrant subclavian artery.
Article in JTCVS techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Video-assisted thoracoscopic surgery with carotid subclavian transposition for embolizing lesion from an aberrant right subclavian artery.Journal of vascular surgery cases and innovative techniques · 2026Article
- Robotic-Assisted Vascular Surgery: Current Landscape, Challenges, and Future Directions.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Aberrant subclavian artery (ASA), though rare, can cause dysphagia lusoria and significantly affect quality of life. Conventional treatment involves open ligation and division of ASA, but a robotic approach is becoming more popular. This study assessed outcomes in patients undergoing robotic ASA division. Methods: We retrospectively reviewed 9 patients with dysphagia who underwent robotic division of ASA between 2021 and 2025. Our standard approach is one-stage robotic ligation and division of the ASA, followed by open subclavian-to-carotid transposition (SCT). Patients undergo continued surveillance for potential thoracic endovascular aortic repair (TEVAR) in the event that Kommerell diverticulum (KD) expands. Patient demographics, presentations, aberrant anatomy, operative details, and outcomes were reviewed. Results: The study cohort had a mean age of 49 years and mean body mass index of 30.5 kg/m Conclusions: This one-stage hybrid approach-robotic ASA division with open SCT-is safe, with no reported postoperative stroke or mortality, and offers excellent patient satisfaction. It provides a minimally invasive alternative for treating dysphagia lusoria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.